Deal snapshot: EU, CHINA REGULATORS CLEAR GERMAN MERCK TO BUY SIGMA ALDRICH
06/16/2015 06:50 PM ET
Jun 16, 2015 (M&A Navigator via COMTEX News Network) -- The European Commission has conditionally cleared the planned acquisition of US-based life sciences company Sigma-Aldrich Corp. (NASDAQ: SIAL) by German drugmaker Merck KGaA, the companies said. Sigma-Aldrich also announced it has obtained full clearance of the transaction from the Chinese Ministry of Commerce. These latest jurisdictions to clear the transaction follow clearance in May by Japanese authorities. Antitrust clearance has also been obtained in the United States, Russia, Serbia, Ukraine, South Africa and Taiwan. On September 22, 2014, Merck KGaA, Darmstadt, Germany, and Sigma-Aldrich announced they had entered into a definitive agreement under which Merck KGaA, Darmstadt, Germany, will acquire Sigma-Aldrich for USD 17bn, or USD 140 cash per share.
Country: USA
Sector: Pharmaceuticals
Target: Sigma-Aldrich Corp
Buyer: Merck KGaA
Vendor:
Deal size in USD: 17bn
Type: Corporate Acquisition
Financing:
Status: Agreed
Buyer advisor: , ,
Comment:
Comments on this story may be sent to info@m2.com
(C)2015 M2 COMMUNICATIONS https://www.m2.com